Protect pharmaceutical innovation

Science

Volumn 328, Issue 5984, 2010, Pages 1354-

  Musselwhite, Laura W ^a   Andrews, Jane ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG COST; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG RESEARCH; FUNDING; GOVERNMENT; LEGAL ASPECT; LETTER; MEDICAL RESEARCH; PRIORITY JOURNAL; PROFIT;

EID: 77953577615     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.328.5984.1354-a     Document Type: Letter

References (4)

1. B. Young, M. Surrusco, "Rx R&D myths: The case against the drug industry's R&D 'scare card,'" Public Citizen (July 2001).
2. The Henry J. Kaiser Family Foundation, "Profitability of pharmaceutical manufacturers" (16 September 2009).
3. Global Forum for Health Research, "Monitoring financial flows for health research" (2006).
4. A. B. Engelberg et al., N. Engl. J. Med. 361, 1917 (2009).